NCT07132827View on ClinicalTrials.gov

Efficacy and Safety of SHR-1905 Injection in Subjects With Chronic Rhinosinusitis With Nasal Polyps

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

April 30, 2028

Study Completion Date

April 30, 2028

Conditions
Chronic Rhinosinusitis With Nasal Polyps
Interventions
DRUG

SHR-1905 Injection

SHR-1905 Injection

DRUG

SHR-1905 Placebo Injection

SHR-1905 Placebo Injection

Trial Locations (1)

200031

Eye & Ent Hospital of Fudan University, Shanghai

All Listed Sponsors
lead

Guangdong Hengrui Pharmaceutical Co., Ltd

INDUSTRY